Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Following a surge of 52.47% during regular trading session on Tuesday, Polyrizon Ltd (NASDAQ: PLRZ) witnessed a dip of 12.02% ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Merck has reached an agreement to acquire British pharmaceutical company Verona Pharma in a deal worth around $10 billion, ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

In this article, we will look at the 10 Biotech Stocks Screaming a Buy. The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott ...